An Essential Difference Between the Flavonoids MonoHER and Quercetin in Their Interplay with the Endogenous Antioxidant Network

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Nov 17

PMID 21079733

Citations 10

Authors

Hilde Jacobs

Mohamed Moalin

Aalt Bast

Wim J F van der Vijgh

Guido R M M Haenen

Affiliations

Soon will be listed here.

Abstract

Antioxidants can scavenge highly reactive radicals. As a result the antioxidants are converted into oxidation products that might cause damage to vital cellular components. To prevent this damage, the human body possesses an intricate network of antioxidants that pass over the reactivity from one antioxidant to another in a controlled way. The aim of the present study was to investigate how the semi-synthetic flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside (monoHER), a potential protective agent against doxorubicin-induced cardiotoxicity, fits into this antioxidant network. This position was compared with that of the well-known flavonoid quercetin. The present study shows that the oxidation products of both monoHER and quercetin are reactive towards thiol groups of both GSH and proteins. However, in human blood plasma, oxidized quercetin easily reacts with protein thiols, whereas oxidized monoHER does not react with plasma protein thiols. Our results indicate that this can be explained by the presence of ascorbate in plasma; ascorbate is able to reduce oxidized monoHER to the parent compound monoHER before oxidized monoHER can react with thiols. This is a major difference with oxidized quercetin that preferentially reacts with thiols rather than ascorbate. The difference in selectivity between monoHER and quercetin originates from an intrinsic difference in the chemical nature of their oxidation products, which was corroborated by molecular quantum chemical calculations. These findings point towards an essential difference between structurally closely related flavonoids in their interplay with the endogenous antioxidant network. The advantage of monoHER is that it can safely channel the reactivity of radicals into the antioxidant network where the reactivity is completely neutralized.

Citing Articles

Exploring the Anticancer Potential of MonoHER (7-Mono-O-(β-Hydroxyethyl)-Rutoside): Mitochondrial-Dependent Apoptosis in HepG2 Cells.

Li C, Wang Y, Liang J, Haenen G, Chen Y, Li Z Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852151 PMC: 11763755. DOI: 10.3390/cimb47010036.

Effect of Administration of an Equal Dose of Selected Dietary Chemicals on Nrf2 Nuclear Translocation in the Mouse Liver.

Alrawaiq N, Atia A, Abdullah A Oxid Med Cell Longev. 2023; 2023:9291417.

PMID: 37077659 PMC: 10110381. DOI: 10.1155/2023/9291417.

Hesperidin Functions as an Ergogenic Aid by Increasing Endothelial Function and Decreasing Exercise-Induced Oxidative Stress and Inflammation, Thereby Contributing to Improved Exercise Performance.

Imperatrice M, Cuijpers I, Troost F, Sthijns M Nutrients. 2022; 14(14).

PMID: 35889917 PMC: 9316530. DOI: 10.3390/nu14142955.

The Role of Circulating Lycopene in Low-Grade Chronic Inflammation: A Systematic Review of the Literature.

van Steenwijk H, Bast A, de Boer A Molecules. 2020; 25(19).

PMID: 32977711 PMC: 7582666. DOI: 10.3390/molecules25194378.

Flavonoids with Glutathione Antioxidant Synergy: Influence of Free Radicals Inflow.

Ilyasov I, Beloborodov V, Antonov D, Dubrovskaya A, Terekhov R, Zhevlakova A Antioxidants (Basel). 2020; 9(8).

PMID: 32756351 PMC: 7465956. DOI: 10.3390/antiox9080695.

References

Galati G, Moridani M, Chan T, OBrien P . Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. Free Radic Biol Med. 2001; 30(4):370-82. DOI: 10.1016/s0891-5849(00)00481-0. View

Bruynzeel A, Niessen H, Bronzwaer J, van der Hoeven J, Berkhof J, Bast A . The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study. Br J Cancer. 2007; 97(8):1084-9. PMC: 2360436. DOI: 10.1038/sj.bjc.6603994. View

Hertog M, Hollman P, Katan M, Kromhout D . Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer. 1993; 20(1):21-9. DOI: 10.1080/01635589309514267. View

Meister A . Glutathione, ascorbate, and cellular protection. Cancer Res. 1994; 54(7 Suppl):1969s-1975s. View

Bast A, Haenen G . The toxicity of antioxidants and their metabolites. Environ Toxicol Pharmacol. 2011; 11(3-4):251-8. DOI: 10.1016/s1382-6689(01)00118-1. View

Petruzzellis V, Troccoli T, Candiani C, Guarisco R, Lospalluti M, Belcaro G . Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study. Angiology. 2002; 53(3):257-63. DOI: 10.1177/000331970205300302. View

Rathee P, Chaudhary H, Rathee S, Rathee D, Kumar V, Kohli K . Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm Allergy Drug Targets. 2009; 8(3):229-35. DOI: 10.2174/187152809788681029. View

Yen G, Duh P, Tsai H, Huang S . Pro-oxidative properties of flavonoids in human lymphocytes. Biosci Biotechnol Biochem. 2003; 67(6):1215-22. DOI: 10.1271/bbb.67.1215. View

Amic D, Davidovic-Amic D, Beslo D, Rastija V, Lucic B, Trinajstic N . SAR and QSAR of the antioxidant activity of flavonoids. Curr Med Chem. 2007; 14(7):827-45. DOI: 10.2174/092986707780090954. View

10.

Bowry V, Ingold K, Stocker R . Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem J. 1992; 288 ( Pt 2):341-4. PMC: 1132016. DOI: 10.1042/bj2880341. View

11.

OBrien P . Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact. 1991; 80(1):1-41. DOI: 10.1016/0009-2797(91)90029-7. View

12.

Jacobs H, van der Vijgh W, Koek G, Draaisma G, Moalin M, van Strijdonck G . Characterization of the glutathione conjugate of the semisynthetic flavonoid monoHER. Free Radic Biol Med. 2009; 46(12):1567-73. DOI: 10.1016/j.freeradbiomed.2009.02.031. View

13.

van Acker F, Van Acker S, Kramer K, Haenen G, Bast A, van der Vijgh W . 7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week. Clin Cancer Res. 2000; 6(4):1337-41. View

14.

Brubacher D, Moser U, Jordan P . Vitamin C concentrations in plasma as a function of intake: a meta-analysis. Int J Vitam Nutr Res. 2000; 70(5):226-37. DOI: 10.1024/0300-9831.70.5.226. View

15.

Packer J, Slater T, Willson R . Direct observation of a free radical interaction between vitamin E and vitamin C. Nature. 1979; 278(5706):737-8. DOI: 10.1038/278737a0. View

16.

Mukai K, Nishimura M, Kikuchi S . Stopped-flow investigation of the reaction of vitamin C with tocopheroxyl radical in aqueous triton X-100 micellar solutions. The structure-activity relationship of the regeneration reaction of tocopherol by vitamin C. J Biol Chem. 1991; 266(1):274-8. View

17.

Haenen G, Bast A . The use of vitamin supplements in self-medication. Therapie. 2002; 57(2):119-22. View

18.

Boots A, Li H, Schins R, Duffin R, Heemskerk J, Bast A . The quercetin paradox. Toxicol Appl Pharmacol. 2007; 222(1):89-96. DOI: 10.1016/j.taap.2007.04.004. View

19.

Boots A, Haenen G, Bast A . Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008; 585(2-3):325-37. DOI: 10.1016/j.ejphar.2008.03.008. View

20.

Kalyanaraman B, Premovic P, Sealy R . Semiquinone anion radicals from addition of amino acids, peptides, and proteins to quinones derived from oxidation of catechols and catecholamines. An ESR spin stabilization study. J Biol Chem. 1987; 262(23):11080-7. View